Barclays Starts 4D Molecular Therapeutics (FDMT) at Overweight

April 15, 2024 3:43 AM EDT Send to a Friend
(Updated - April 15, 2024 4:33 AM EDT)

Barclays analyst Gena Wang initiates coverage on 4D Molecular Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login